MGFA has partnered with Bionews to feature the “Myasthenia Gravis News” feed on our MGFA website. We are excited to offer the MG Community this insightful and informative news feed that covers many aspects of living with myasthenia – from research and study results to managing MG, helpful tips, and important news from across the MG World.
Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, BioNews seeks the opinion of outside experts for interviews and Q&As.
Myasthenia Gravis News – The Web’s Daily Resource for Myasthenia Gravis News
- ‘FDA-aligned’ trial of KYV-101 for MG likely to start enrolling this year
by Marisa Wexler, MS on September 2, 2025 at 1:30 pmA new Phase 3 clinical trial testing Kyverna Therapeutics’ cell therapy candidate KYV-101 in people with myasthenia gravis (MG) — a study the developer says “supports [a] clear and rapid path The post ‘FDA-aligned’ trial of KYV-101 for MG likely to start enrolling this year appeared first on Myasthenia Gravis News.
- My twin with MG takes several precautions before going outside
by Allen Francis on August 29, 2025 at 2:00 pmI don’t enjoy going outside now as much as I did in my youth. I’m a homebody and I like it. This transition made me think of my twin, Aaron, The post My twin with MG takes several precautions before going outside appeared first on Myasthenia Gravis News.
- Stress is the real enemy when living with myasthenia gravis
by Sarah Bendiff on August 28, 2025 at 2:00 pmI haven’t had a disease flare-up recently or a full physical and mental breakdown. Still, this year has been a roller coaster for me. Each month seems to follow a The post Stress is the real enemy when living with myasthenia gravis appeared first on Myasthenia Gravis News.
- Small victories offer hope amid the relentless struggle with MG
by Mark Harrington on August 27, 2025 at 2:00 pmLiving with myasthenia gravis (MG) doesn’t always involve big, cinematic moments of triumph. Instead, progress often comes in small victories. Some days, just finishing the laundry or making a grocery The post Small victories offer hope amid the relentless struggle with MG appeared first on Myasthenia Gravis News.
- Cemdisiran significantly eases disease activity in gMG adults
by Steve Bryson, PhD on August 27, 2025 at 1:00 pmCemdisiran, an under-the-skin injection therapy given every three months, significantly reduced disease activity in people with generalized myasthenia gravis (gMG) after six months of treatment. That’s according to data from The post Cemdisiran significantly eases disease activity in gMG adults appeared first on Myasthenia Gravis News.
** MGFA Disclaimer – Please read
Myasthenia Gravis Foundation of America (MGFA) and Bionews, Inc. (specifically Myasthenia Gravis News) have entered into a limited agreement that allows for the MGFA to post a link to Myasthenia Gravis News on the myasthenia.org website. Myasthenia Gravis News is a digital platform intended to provide the myasthenia gravis (MG) community with the most recent news and information on MG, as well as first-hand community perspectives from patient and caregiver columnists. All articles on Myasthenia Gravis News are original content produced by in-house writers and editors. Occasionally, Bionews seeks the opinion of outside experts for interviews and Q&As.
The publishing team at Myasthenia Gravis News is made up of science writers and editors, most of whom have PhDs in the life sciences; veteran journalists; and columnists who are members of the MG community. Together, they attempt to ensure that all content published on Myasthenia Gravis News is relevant, accurate, informative, relatable, and easy to understand.
Each piece of content is carefully selected and written by Bionews writers with the MG community in mind. Sources for news stories and resource pages include peer-reviewed studies, press releases, announcements, interviews, webinars, and conference sessions, among others. All articles go through a stringent fact-checking and editing procedure as part of Bionews’ process to ensure they are accurate, objective, comprehensive, and well-explained.
Columns are written by MG patients and caregivers who provide an intimate look at what it’s like to live with the disease. While columns are largely opinion and perspective pieces, each one still goes through a comprehensive editing and fact-checking process by Bionews editors to ensure clarity, accuracy, and fairness.
Myasthenia Gravis News’ site is strictly a news and information website about the disease. It DOES NOT provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The information provided is for educational purposes only and does not substitute for professional medical advice.
The content reflects the unique experiences of the authors and is not necessarily the opinion, views, or recommendations of the MGFA. Medical advisors and clinicians associated with or partnering with the MGFA do not peer review articles and information posted on the Myasthenia Gravis News platform or website. MGFA should not be liable for any information, opinions, articles, advice, guidance, or details posted on the Myasthenia Gravis News site. MGFA has posted this platform as a service to the MG community. Please consult with your doctor and healthcare professionals for specific recommendations and advice pertaining to your healthcare/treatment.